[Oxford]
Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis: a systematic review and meta-analysis
Authors£ºLine Uhrenholt; Robin Christensen; Wilfred K H Dinesen; Caroline H Liboriussen; Stine S Andersen; Lene Dreyer; Annette Schlemmer; Ellen-Margrethe Hauge; Conni Skrubbeltrang; Peter C Taylor; Salome Kristensen